Matches in Wikidata for { <http://www.wikidata.org/entity/Q89410666> ?p ?o ?g. }
- Q89410666 description "2018 nî lūn-bûn" @default.
- Q89410666 description "2018年の論文" @default.
- Q89410666 description "2018年学术文章" @default.
- Q89410666 description "2018年学术文章" @default.
- Q89410666 description "2018年学术文章" @default.
- Q89410666 description "2018年学术文章" @default.
- Q89410666 description "2018年学术文章" @default.
- Q89410666 description "2018年学术文章" @default.
- Q89410666 description "2018年學術文章" @default.
- Q89410666 description "2018年學術文章" @default.
- Q89410666 description "2018年學術文章" @default.
- Q89410666 description "2018年學術文章" @default.
- Q89410666 description "2018年學術文章" @default.
- Q89410666 description "2018년 논문" @default.
- Q89410666 description "article científic" @default.
- Q89410666 description "article scientific" @default.
- Q89410666 description "article scientifique" @default.
- Q89410666 description "articol științific" @default.
- Q89410666 description "articolo scientifico" @default.
- Q89410666 description "artigo científico" @default.
- Q89410666 description "artigo científico" @default.
- Q89410666 description "artigo científico" @default.
- Q89410666 description "artikel ilmiah" @default.
- Q89410666 description "artikull shkencor" @default.
- Q89410666 description "artikulong pang-agham" @default.
- Q89410666 description "artykuł naukowy" @default.
- Q89410666 description "artículo científico publicado en 2018" @default.
- Q89410666 description "artículu científicu" @default.
- Q89410666 description "bilimsel makale" @default.
- Q89410666 description "bài báo khoa học" @default.
- Q89410666 description "naučni članak" @default.
- Q89410666 description "scienca artikolo" @default.
- Q89410666 description "scientific article published in July 2018" @default.
- Q89410666 description "scientific article published in July 2018" @default.
- Q89410666 description "scientific article published on 01 July 2018" @default.
- Q89410666 description "teaduslik artikkel" @default.
- Q89410666 description "tieteellinen artikkeli" @default.
- Q89410666 description "tudományos cikk" @default.
- Q89410666 description "vedecký článok" @default.
- Q89410666 description "vetenskaplig artikel" @default.
- Q89410666 description "videnskabelig artikel udgivet juli 2018" @default.
- Q89410666 description "vitenskapelig artikkel" @default.
- Q89410666 description "vitskapeleg artikkel" @default.
- Q89410666 description "vědecký článek" @default.
- Q89410666 description "wetenschappelijk artikel" @default.
- Q89410666 description "wissenschaftlicher Artikel" @default.
- Q89410666 description "επιστημονικό άρθρο" @default.
- Q89410666 description "мақолаи илмӣ" @default.
- Q89410666 description "наукова стаття, опублікована в липні 2018" @default.
- Q89410666 description "научна статия" @default.
- Q89410666 description "научная статья" @default.
- Q89410666 description "научни чланак" @default.
- Q89410666 description "научни чланак" @default.
- Q89410666 description "מאמר מדעי" @default.
- Q89410666 description "مقالة علمية نشرت في يوليو 2018" @default.
- Q89410666 description "জুলাই ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q89410666 description "บทความทางวิทยาศาสตร์" @default.
- Q89410666 description "სამეცნიერო სტატია" @default.
- Q89410666 name "Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer" @default.
- Q89410666 name "Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer" @default.
- Q89410666 type Item @default.
- Q89410666 label "Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer" @default.
- Q89410666 label "Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer" @default.
- Q89410666 prefLabel "Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer" @default.
- Q89410666 prefLabel "Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer" @default.
- Q89410666 P1433 Q89410666-7B155F93-7541-44AE-9693-AE6C48063C96 @default.
- Q89410666 P1476 Q89410666-69DD1B1D-4770-4794-BE78-89D86D3B64F7 @default.
- Q89410666 P2093 Q89410666-0068372D-6593-49F9-A6E0-0E4CBF318D48 @default.
- Q89410666 P2093 Q89410666-034BC386-4C06-4CDD-AB2F-B449DCEAAA8D @default.
- Q89410666 P2093 Q89410666-39819D4C-6A48-486C-96D9-E7B931EA2366 @default.
- Q89410666 P2093 Q89410666-644C0745-569C-47D9-B032-1E471C8CBCEB @default.
- Q89410666 P2093 Q89410666-64A76289-E96D-4E48-A566-2B90DE07D95F @default.
- Q89410666 P2093 Q89410666-8092A59B-1897-4F6F-896D-B3628B9E77A0 @default.
- Q89410666 P2093 Q89410666-8C2F3300-0458-47AF-990B-6310478B0D1E @default.
- Q89410666 P2093 Q89410666-93F46E1E-DBB1-483B-932F-E4DE929EBD8B @default.
- Q89410666 P2093 Q89410666-B6E1903B-5E11-4CE5-8A62-0432CE13FFF4 @default.
- Q89410666 P2093 Q89410666-B8A7CB6D-0B26-4E0A-8643-2FDAF1B63555 @default.
- Q89410666 P2093 Q89410666-BCC9BDA2-4528-422C-8000-1C5F4A1A9E41 @default.
- Q89410666 P2093 Q89410666-D04C59D6-00EE-4948-993E-A2B31D974D4A @default.
- Q89410666 P2093 Q89410666-DE58E6E4-0741-4DAE-8EE8-2BB192A41F3A @default.
- Q89410666 P2093 Q89410666-EF1688F0-F172-47CE-BA88-BDDD747D3FE7 @default.
- Q89410666 P2093 Q89410666-F0CCAA2B-B93A-4FE4-AF20-023755A8C62F @default.
- Q89410666 P304 Q89410666-AFC25DE7-C090-437B-BB45-73A0F8300195 @default.
- Q89410666 P31 Q89410666-C264FC69-1055-4C17-8CE5-E9E0B89B6059 @default.
- Q89410666 P356 Q89410666-35245ACC-B0B6-4C1B-AF3B-10321834B0B3 @default.
- Q89410666 P433 Q89410666-4FACD175-F2CC-4FB9-9EB3-1184CCD41280 @default.
- Q89410666 P478 Q89410666-AF209CC1-065E-43B7-B30A-BC0CFB5E3F7E @default.
- Q89410666 P577 Q89410666-C1F39E0A-340E-4C06-A6E3-0DEA001AE709 @default.
- Q89410666 P698 Q89410666-B1D9D976-5B67-4986-A7CD-21B44BB2167E @default.
- Q89410666 P921 Q89410666-BDEAFF56-800B-44B9-B986-1246893C2F8E @default.
- Q89410666 P921 Q89410666-E2E7D004-2274-4DA2-AAA3-7E2534215553 @default.
- Q89410666 P356 ANTICANRES.12697 @default.
- Q89410666 P698 29970533 @default.
- Q89410666 P1433 Q326290 @default.
- Q89410666 P1476 "Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer" @default.
- Q89410666 P2093 "Akira Sakuyama" @default.
- Q89410666 P2093 "Hiroki Tanaka" @default.
- Q89410666 P2093 "Hiroshi Koyama" @default.
- Q89410666 P2093 "Ikuya Fujiwara" @default.
- Q89410666 P2093 "Katsuhiko Nakatsukasa" @default.